grab the latest..
Whitepapers
A comprehensive overview of
The EU Regulatory Landscape for Generic
Drug Approval
BLOOD-BRAIN-BARRIER
The Blood-Brain Barrier (BBB) is a highly selective, semi-permeable membrane between the blood and the interstitium of the brain, allowing cerebral blood vessels to regulate molecule and ion movement between the blood and the brain
Narcolepsy Type 1 (NT1)
Narcolepsy is a chronic neurological disorder that affects the brain’s ability to control sleep-wake cycles
LIFE CYCLE MANAGEMENT STRATEGY (LCMS)
Life cycle management strategy (LCMS) is a systematic approach used by pharmaceutical companies
THYROID EYE DISEASE
It is an autoimmune condition in which the immune system mistakenly attacks the muscles and fatty tissues behind the eyes.
Beta Thalassemia
Beta thalassemia is an autosomal recessive blood disorder caused by mutations in the HBB gene on chromosome 11
Obesity Treatment
Obesity is a chronic disease associated with a broad spectrum of metabolic, biomechanical and psychosocial complications that emerge across the lifespan.
Latest whitepapers
An emerging class of therapies but facing setbacks
2023 insights into Swissmedic authorization of human medicinal products featuring a new active substance and additional indications
Discover the process of development, manufacturing, and mitigation of challenges associated with mRNA vaccines